Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-07-26 Sale |
2021-07-28 09:11 am |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
103 | $15.3 | $1,576 | 21,238 (Direct) |
View |
| 2021-05-17 Purchase |
2021-05-18 11:36 am |
UroGen Pharma Ltd. | URGN | Henderson Molly Chief Financial Officer |
2,500 | $15.85 | $39,625 | 2,500 (Direct) |
View |
| 2021-05-17 Purchase |
2021-05-18 11:35 am |
UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel |
2,500 | $15.71 | $39,275 | 2,500 (Direct) |
View |
| 2021-04-30 Sale |
2021-05-04 1:58 pm |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
243 | $20 | $4,860 | 24,632 (Direct) |
View |
| 2021-04-26 Sale |
2021-04-27 1:44 pm |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
89 | $19.63 | $1,747 | 21,500 (Direct) |
View |
| 2021-01-31 Sale |
2021-02-02 2:53 pm |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
1,076 | $22.07 | $23,747 | 51,755 (Direct) |
View |
| 2021-01-26 Sale |
2021-01-26 5:20 pm |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
100 | $22.12 | $2,212 | 20,665 (Direct) |
View |
| 2020-12-14 Purchase |
2020-12-15 5:27 pm |
UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer |
10,000 | $18.5 | $185,000 | 229,117 (Direct) |
View |
| 2020-12-04 Sale |
2020-12-07 3:59 pm |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
662 | $19.85 | $13,141 | 19,723 (Direct) |
View |
| 2020-10-26 Sale |
2020-10-28 2:12 pm |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
101 | $20.95 | $2,116 | 20,385 (Direct) |
View |
| 2020-10-15 Sale |
2020-10-16 3:41 pm |
UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. Chief Financial Officer |
2,400 | $21.77 | $52,248 | 18,154 (Direct) |
View |
| 2020-09-04 Sale |
2020-09-08 4:48 pm |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
348 | $20.2 | $7,030 | 20,278 (Direct) |
View |
| 2020-09-01 Sale |
2020-09-01 2:37 pm |
UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. Chief Financial Officer |
509 | $22.82 | $11,615 | 12,054 (Direct) |
View |
| 2020-07-27 Sale |
2020-07-28 5:34 pm |
UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. Chief Financial Officer |
141 | $23.51 | $3,315 | 9,855 (Direct) |
View |
| 2020-07-27 Sale |
2020-07-28 5:32 pm |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
70 | $23.51 | $1,646 | 19,793 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-07-26 Exercise |
2021-07-28 09:11 am |
N/A N/A |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
208 | $0 | 21,238 (Direct) |
View |
| 2020-06-03 Exercise(A) |
2021-07-12 6:59 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer |
61,652 | $0 | 1,205,551 (Direct) |
View |
| 2021-03-26 Exercise(A) |
2021-06-09 1:47 pm |
2014-07-27 2021-07-27 |
UroGen Pharma Ltd. | URGN | Belldegrun Arie Director |
3,241 | $0 | 245,452 (Direct) |
View |
| 2021-03-26 Exercise(A) |
2021-06-09 1:47 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Belldegrun Arie Director |
3,241 | $5 | 245,452 (Direct) |
View |
| 2021-03-25 Exercise(A) |
2021-06-09 1:46 pm |
2014-07-27 2021-07-27 |
UroGen Pharma Ltd. | URGN | Nussbaum Ran Director |
1,030 | $0 | 1,431,717 (Indirect) |
View |
| 2021-03-25 Exercise(A) |
2021-06-09 1:46 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Nussbaum Ran Director |
1,030 | $5 | 1,431,717 (Indirect) |
View |
| 2021-06-07 Option Award |
2021-06-09 1:45 pm |
N/A 2031-06-07 |
UroGen Pharma Ltd. | URGN | Cohen Fred E Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2021-06-07 Option Award |
2021-06-09 1:44 pm |
N/A 2031-06-06 |
UroGen Pharma Ltd. | URGN | BUTITTA CYNTHIA M Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2021-06-07 Option Award |
2021-06-09 1:43 pm |
N/A 2031-06-06 |
UroGen Pharma Ltd. | URGN | FALBERG KATHRYN E Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2021-06-07 Option Award |
2021-06-09 1:43 pm |
N/A 2031-06-06 |
UroGen Pharma Ltd. | URGN | Tomasello Shawn Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2021-03-25 Exercise |
2021-06-09 1:42 pm |
2014-07-27 2021-07-27 |
UroGen Pharma Ltd. | URGN | Nussbaum Ran Director |
2,211 | $0 | 1,443,928 (Indirect) |
View |
| 2021-06-07 Option Award |
2021-06-09 1:42 pm |
N/A 2031-06-06 |
UroGen Pharma Ltd. | URGN | Nussbaum Ran Director |
10,000 | $0 | 1,443,928 (Indirect) |
View |
| 2021-03-25 Exercise |
2021-06-09 1:42 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Nussbaum Ran Director |
2,211 | $5 | 1,443,928 (Indirect) |
View |
| 2021-06-07 Option Award |
2021-06-09 1:41 pm |
N/A 2031-06-06 |
UroGen Pharma Ltd. | URGN | Belldegrun Arie Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2021-06-07 Option Award |
2021-06-09 1:41 pm |
N/A 2031-06-06 |
UroGen Pharma Ltd. | URGN | Holden Stuart Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2021-06-05 Option Award |
2021-06-08 2:33 pm |
N/A 2031-05-31 |
UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-06-05 Option Award |
2021-06-08 2:33 pm |
N/A 2031-05-31 |
UroGen Pharma Ltd. | URGN | Henderson Molly Chief Financial Officer |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-01-03 Exercise |
2021-05-21 1:44 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer |
13,807 | $0 | 355,188 (Direct) |
View |
| 2021-05-19 Tax Withholding |
2021-05-21 1:44 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer |
3,425 | $17.51 | 355,188 (Direct) |
View |
| 2021-04-30 Exercise |
2021-05-04 1:58 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
500 | $0 | 24,632 (Direct) |
View |
| 2021-04-26 Exercise |
2021-04-27 1:44 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
209 | $0 | 21,500 (Direct) |
View |
| 2021-03-24 Exercise |
2021-04-22 5:19 pm |
2014-07-27 2021-07-27 |
UroGen Pharma Ltd. | URGN | Belldegrun Arie Director |
3,241 | $0 | 245,452 (Direct) |
View |
| 2021-03-24 Exercise |
2021-04-22 5:19 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Belldegrun Arie Director |
3,241 | $5 | 245,452 (Direct) |
View |
| 2021-03-24 Exercise |
2021-04-22 5:18 pm |
2014-07-27 2021-07-27 |
UroGen Pharma Ltd. | URGN | Nussbaum Ran Director |
1,030 | $0 | 1,465,199 (Indirect) |
View |
| 2021-03-24 Exercise |
2021-04-22 5:18 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Nussbaum Ran Director |
1,030 | $5 | 1,465,199 (Indirect) |
View |
| 2021-01-31 Option Award |
2021-02-02 3:57 pm |
N/A 2031-01-30 |
UroGen Pharma Ltd. | URGN | Henderson Molly Chief Financial Officer |
8,000 | $0 | 8,000 (Direct) |
View |
| 2021-01-31 Option Award |
2021-02-02 3:55 pm |
N/A 2031-01-30 |
UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel |
10,500 | $0 | 10,500 (Direct) |
View |
| 2021-01-31 Option Award |
2021-02-02 2:54 pm |
N/A 2031-01-31 |
UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer |
190,000 | $0 | 190,000 (Direct) |
View |
| 2021-01-31 Exercise |
2021-02-02 2:53 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
2,000 | $0 | 51,755 (Direct) |
View |
| 2021-01-31 Option Award |
2021-02-02 2:53 pm |
N/A 2031-01-31 |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
27,000 | $0 | 51,755 (Direct) |
View |
| 2021-01-26 Exercise |
2021-01-26 5:20 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
208 | $0 | 20,665 (Direct) |
View |
| 2020-12-04 Exercise |
2020-12-07 3:59 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
1,042 | $0 | 19,723 (Direct) |
View |
| 2020-12-04 Exercise |
2020-12-04 4:35 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer |
61,652 | $0 | 333,613 (Direct) |
View |
| 2020-10-26 Exercise |
2020-10-28 2:12 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
208 | $0 | 20,385 (Direct) |
View |
| 2020-10-15 Exercise |
2020-10-16 3:41 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. Chief Financial Officer |
9,834 | $0 | 18,154 (Direct) |
View |
| 2020-10-01 Option Award |
2020-10-05 4:37 pm |
N/A 2030-09-30 |
UroGen Pharma Ltd. | URGN | Henderson Molly Chief Financial Officer |
75,000 | $0 | 75,000 (Direct) |
View |
| 2020-10-01 Option Award(A) |
2020-10-05 4:35 pm |
N/A 2030-09-30 |
UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel |
85,000 | $0 | 85,000 (Direct) |
View |
| 2020-09-09 Option Award |
2020-09-10 12:14 pm |
N/A 2030-09-08 |
UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel |
85,000 | $0 | 85,000 (Direct) |
View |
| 2020-09-04 Exercise |
2020-09-08 4:48 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
1,041 | $0 | 20,278 (Direct) |
View |
| 2020-09-01 Exercise |
2020-09-01 2:37 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. Chief Financial Officer |
1,042 | $0 | 12,054 (Direct) |
View |
| 2020-07-26 Exercise |
2020-07-28 5:34 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. Chief Financial Officer |
417 | $0 | 9,855 (Direct) |
View |
| 2020-07-26 Exercise |
2020-07-28 5:32 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
209 | $0 | 19,793 (Direct) |
View |
| 2020-06-08 Option Award |
2020-06-10 6:43 pm |
N/A 2030-06-07 |
UroGen Pharma Ltd. | URGN | Tomasello Shawn Director |
10,000 | $0 | 10,000 (Direct) |
View |